Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 24, 2020 - Issue 7
Submit an article Journal homepage
280
Views
3
CrossRef citations to date
0
Altmetric
Review

LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?

Shaun Egolfa Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA;b Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0001-5920-0144View further author information
ORCID Icon &
Brian C. Capella Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA;b Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA;c Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA;d Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7036-8359View further author information
ORCID Icon
Pages 671-678 | Received 10 Feb 2020, Accepted 26 Apr 2020, Published online: 07 May 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tejas P. Joshi, Morgan A. Farr & Daniel J. Lewis. (2021) Epigenetic regulatory mechanisms of histone acetylation in the treatment of cutaneous squamous cell carcinoma. Expert Opinion on Therapeutic Targets 25:11, pages 1025-1026.
Read now

Articles from other publishers (2)

Justine Galambus & Kenneth Y. Tsai. (2022) Molecular and immune targets in cutaneous squamous cell carcinoma. Molecular Carcinogenesis 62:1, pages 38-51.
Crossref
Xiangyu Zhang, Xinran Wang, Tianxiao Wu, Wenbo Yin, Jiangkun Yan, Yixiang Sun & Dongmei Zhao. (2022) Therapeutic potential of targeting LSD1/ KDM1A in cancers. Pharmacological Research 175, pages 105958.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.